Skip to main content
Signal8

Mayers Ventures LLC Form SCHEDULE 13D — Sep 17, 2026

Form SCHEDULE 13DFiled Sep 17, 2026, 4:03 PM ET0001213900-26-100950Original filing

Mayers Ventures LLC and Ram Naim filed a Schedule 13D reporting beneficial ownership of 130,000 shares, approximately 4.86%, of Tessera Defense and Homeland Security Inc. (formerly BiomX Inc.) common stock, with an event date of September 16, 2026. The shares were acquired without any cash outlay, as consideration for the LLC's sale of 15% of the issued and outstanding share capital of M.E.A. Testing Systems Ltd., an Israeli private company, under a Share Purchase and Option Agreement dated August 5, 2026.

Key figures

Debt Amount
$475,000 convertible loan facility made available by the Issuer to Mayers Ventures LLC
Interest Rate
12
Shares Outstanding
2672387
Cusip
09090D608
Event Date
2026-09-16
Mea Equity Sold
15% of M.E.A. Testing Systems Ltd., plus an additional 5% for 65,000 more issuer shares
Percent Of Class
4.86%
Beneficial Shares
130000
Reverse Split Ratio
1:10
Additional Entitled Shares
65000
Shareholder Reference Date
2026-08-19

AI analysis

Red flags5 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.

    Mayers Ventures LLC Form SCHEDULE 13D — Sep 17, 2026: AI Analysis | Signal8